Literature DB >> 31754957

Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease.

Yong-Ho Lee1,2, Seung Up Kim3,4,5.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31754957     DOI： 10.1007/s12072-019-09999-4

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  12 in total

Review 1.  Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.

Authors:  Rahima A Bhanji; Praveena Narayanan; Alina M Allen; Harmeet Malhi; Kymberly D Watt
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

Review 2.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

Review 3.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Authors:  Parambir S Dulai; Siddharth Singh; Janki Patel; Meera Soni; Larry J Prokop; Zobair Younossi; Giada Sebastiani; Mattias Ekstedt; Hannes Hagstrom; Patrik Nasr; Per Stal; Vincent Wai-Sun Wong; Stergios Kechagias; Rolf Hultcrantz; Rohit Loomba
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

4.  Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.

Authors:  Gyuri Kim; Seung-Eun Lee; You-Bin Lee; Ji Eun Jun; Jiyeon Ahn; Ji Cheol Bae; Sang-Man Jin; Kyu Yeon Hur; Jae Hwan Jee; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Hepatology       Date:  2018-10-14       Impact factor: 17.425

5.  Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).

Authors:  Yong-ho Lee; Seung Up Kim; Kijun Song; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha; Kwang-Hyub Han
Journal:  Hepatology       Date:  2016-01-14       Impact factor: 17.425

6.  Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.

Authors:  Donghee Kim; Andrew A Li; Chiranjeevi Gadiparthi; Muhammad Ali Khan; George Cholankeril; Jeffrey S Glenn; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2018-09-01       Impact factor: 22.682

7.  Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Changzhou Cai; Xin Song; Yishu Chen; Xueyang Chen; Chaohui Yu
Journal:  Hepatol Int       Date:  2019-07-09       Impact factor: 6.047

8.  The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.

Authors:  Stephanie A Studenski; Katherine W Peters; Dawn E Alley; Peggy M Cawthon; Robert R McLean; Tamara B Harris; Luigi Ferrucci; Jack M Guralnik; Maren S Fragala; Anne M Kenny; Douglas P Kiel; Stephen B Kritchevsky; Michelle D Shardell; Thuy-Tien L Dam; Maria T Vassileva
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

Review 9.  Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.

Authors:  Eugene Han; Yong Ho Lee
Journal:  Diabetes Metab J       Date:  2017-11-17       Impact factor: 5.376

10.  Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.

Authors:  Min Jung Lee; Eun-Hee Kim; Sung-Jin Bae; Gi-Ae Kim; Sung Won Park; Jaewon Choe; Chang Hee Jung; Woo Je Lee; Hong-Kyu Kim
Journal:  Gut Liver       Date:  2019-01-15       Impact factor: 4.519
View more
  1 in total

Review 1.  Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.

Authors:  Renyi Su; Xuyong Wei; Qiang Wei; Di Lu; Zuyuan Lin; Shuo Wang; Chuxiao Shao; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.